Vanguard Fiduciary Trust
PAVM icon

Vanguard Fiduciary Trust’s PAVmed PAVM Stock Holding History

Vanguard Fiduciary Trust’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$152K Buy
25,605
+20,176
+372% +$143K ﹤0.01% 3647
2026
Q1 		$55.1K Buy
+5,429
New +$51.4K ﹤0.01% 3813

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return

Vanguard Fiduciary Trust's PAVM Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its PAVmed (PAVM) stake by 372% in Q2 2026, buying an estimated $143K and bringing the position to 25,605 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #3647.

Vanguard Fiduciary Trust first reported a position in PAVM in Q1 2026 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold PAVM as of Q2 2026.

  • Vanguard Fiduciary Trust held 25,605 shares of PAVmed worth $152K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 20,176 PAVmed shares in Q2 2026, an estimated $143K.
  • PAVmed made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3647 holding.
  • Vanguard Fiduciary Trust first reported a position in PAVmed in Q1 2026 and has held it in 2 quarters since.
  • 19 funds tracked by Wall St. Rank held PAVmed as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.